sertraline has been researched along with Weight Gain in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, A; Bielinski, SJ; Camilleri, M; Cifuentes, L; Decker, PA; Gonzalez-Izundegui, D; Hurtado, MD; Moyer, AM; Ricardo-Silgado, ML; Singh, S | 1 |
| Audi, EA; Cuman, RK; Maraschin, JC; Rangel, MP; Sestile, CC | 1 |
| Araneda, K; Berríos, C; Bravo, JA; Castañeda, P; Díaz-Veliz, G; Fiedler, JL; Menares, C; Mora, S; Morales, P; Ulloa, JL | 1 |
| Albert, U; Bogetto, F; Maina, G; Salvi, V | 1 |
| Bodnar, LM; Sunder, KR; Wisner, KL | 1 |
| Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
| Caswell, M; Flint, AJ; Heo, M; Meyers, BS; Mulsant, BH; Papademetriou, E; Peasley-Miklus, C; Rothschild, AJ; Smith, E | 1 |
| Bryant, SG; Fisher, S; Kent, TA | 1 |
| Hasert, M; Higley, J; Linnoila, M; Suomi, S | 1 |
| Sansone, RA; Shrader, JA; Wiederman, MW | 1 |
| Fava, M; Hoog, SL; Judge, R; Koke, SC; Nilsson, ME | 1 |
5 trial(s) available for sertraline and Weight Gain
| Article | Year |
|---|---|
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2004 |
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
Weight gain during olanzapine treatment for psychotic depression: effects of dose and age.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Benzodiazepines; Canada; Depression; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Olanzapine; Risk Factors; Sertraline; Treatment Outcome; United States; Weight Gain | 2008 |
The serotonin reuptake inhibitor sertraline reduces excessive alcohol consumption in nonhuman primates: effect of stress.
Topics: 1-Naphthylamine; Alcohol Drinking; Animals; Cross-Over Studies; Eating; Female; Hormones; Macaca mulatta; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress, Psychological; Time Factors; Weight Gain | 1998 |
Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
Topics: Adult; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Longitudinal Studies; Male; Middle Aged; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2000 |
7 other study(ies) available for sertraline and Weight Gain
| Article | Year |
|---|---|
Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study.
Topics: Body Weight; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Fluoxetine; Humans; Paroxetine; Phenotype; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2022 |
Antidepressant-like Effect of Insulin in Streptozotocin-induced Type 2 Diabetes Mellitus Rats.
Topics: Animals; Antidepressive Agents; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucose Intolerance; Insulin; Male; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2016 |
Comparison of the antidepressant sertraline on differential depression-like behaviors elicited by restraint stress and repeated corticosterone administration.
Topics: Adrenal Glands; Animals; Antidepressive Agents, Second-Generation; Anxiety; Avoidance Learning; Conditioning, Operant; Corticosterone; Depression; Male; Organ Size; Rats; Rats, Sprague-Dawley; Rats, Wistar; Restraint, Physical; Sertraline; Stress, Psychological; Swimming; Weight Gain | 2010 |
Treatment with selective serotonin reuptake inhibitors during pregnancy: deceleration of weight gain because of depression or drug?
Topics: Adult; Depressive Disorder, Major; Feeding and Eating Disorders; Female; Humans; Nutrition Therapy; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2006 |
Postmarketing surveillance by patient self-monitoring: preliminary data for sertraline versus fluoxetine.
Topics: 1-Naphthylamine; Adult; Adverse Drug Reaction Reporting Systems; Aggression; Ambulatory Care; Confidence Intervals; Data Collection; Drug Monitoring; Female; Fluoxetine; Health Status; Humans; Male; Middle Aged; Patient Compliance; Probability; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Self Care; Sertraline; Telephone; Weight Gain | 1995 |
Naturalistic study of the weight effects of amitriptyline, fluoxetine, and sertraline in an outpatient medical setting.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Female; Fluoxetine; Humans; Male; Middle Aged; Retrospective Studies; Sertraline; Weight Gain | 2000 |
Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
Topics: Adult; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Nausea; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Weight Gain | 2001 |